Background illustration for clinical trials search

Paid Clinical Trials Salem

Discover 955 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.

for
Juvenile Idiopathic Arthritis
Location: Portland OR, Phoenix AZ, Cincinnati OH,
Sponsor: AbbVie

Sex: All

Age: 1 - 17

Code: NCT05609630

Phase 3, Recruiting

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

for
Medulloblastoma
Location: Portland OR, Sacramento CA, Oakland CA, Stanford CA,
Sponsor: Giselle Sholler

Sex: All

Age: 0 - 21

Code: NCT04696029

Phase 2, Recruiting

De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

for
Congenital Diaphragmatic Hernia
Location: Portland OR, Seattle WA, Palo Alto CA,
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 0

Code: NCT05213676

Phase 4, Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for
Rhabdomyosarcoma
Location: Portland OR, Tacoma WA, Seattle WA, Reno NV, Oakland CA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase 3, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,
Location: Portland OR, Tacoma WA, Seattle WA, Spokane WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

for
Osteosarcoma, Ewing Sarcoma
Location: Portland OR, Hershey PA, Tampa FL
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 0 - 50

Code: NCT07321912

Phase 2, Recruiting

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Portland OR, Seattle WA, Spokane WA, Reno NV,
Sponsor: Children's Oncology Group

Sex: All

Age: 15 - 20

Code: NCT06410209

Phase 2, Recruiting

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

for
Rheumatic Joint Disease
Location: Portland OR, Seattle WA, San Francisco CA, Palo Alto CA,
Sponsor: Duke University

Sex: All

Age: 0 - 21

Code: NCT02418442

Recruiting

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

for
Neuroblastoma
Location: Portland OR, Oakland CA, Calgary, San Diego CA,
Sponsor: Giselle Sholler

Sex: All

Age: 0 - 22

Code: NCT02559778

Phase 2, Recruiting

Beat Childhood Cancer Specimen Banking and Data Registry

for
Pediatric Cancer, Survivorship
Location: Portland OR, San Diego CA, Minneapolis MN,
Sponsor: Giselle Sholler

Sex: All

Age: 0+

Code: NCT04715178

Recruiting

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

for
Ovarian Neoplasms, Ovarian Cancer
Location: Portland OR, Reno NV, Walnut Creek CA, La Jolla CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07318558

Phase 3, Recruiting

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Portland OR, Seattle WA, Boise ID, Salt Lake City UT,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07063745

Phase 2, Phase 3, Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: Portland OR, Eugene OR, Olympia WA, Reno NV,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase 3, Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Portland OR, Issaquah WA, Seattle WA, Edmonds WA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 0+

Code: NCT06031688

Phase 2, Recruiting

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

for
Breast Carcinoma, Colorectal Carcinoma,
Location: Portland OR, Issaquah WA, Seattle WA, Bellevue WA,
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT06418204

Recruiting

Study of Enhanced Programming Stimulation with the Enterra® Therapy System

for
Gastroparesis, Gastroparesis Nondiabetic,
Location: Portland OR, Seattle WA, Saint Louis MO, Louisville KY,
Sponsor: Enterra Medical, Inc.

Sex: All

Age: 18 - 70

Code: NCT06560307

Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,
Location: Portland OR, Eugene OR, Calgary, Los Angeles CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07221149

Phase 2, Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

for
Small Cell Lung Cancer
Location: Portland OR, Aurora CO, Milwaukee WI, Chicago IL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06780137

Phase 1, Phase 2, Recruiting

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

for
NSCLC, Stage I
Location: Portland OR, Omaha NE, Minneapolis MN, Iowa City IA,
Sponsor: Greg Durm, MD

Sex: All

Age: 18+

Code: NCT04317534

Phase 2, Recruiting

SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer

for
Oropharyngeal Cancer
Location: Portland OR, Vancouver, Duarte CA, Corona CA, Winnipeg,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT05451004

Phase 3, Recruiting